These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2123131)

  • 1. Intravenous propafenone reduces energy requirements for defibrillation in pigs.
    Montenero AS; Bombardieri G; Barilaro C; Di Francesco P; Santarelli P; Calvi V; Schiavello R; Alessandrini F; Pisanò E; Salsano M
    Cardiologia; 1990 Apr; 35(4):291-4. PubMed ID: 2123131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of intravenous propafenone on the internal ventricular defibrillation threshold in the anesthetized dog.
    Peters W; Gang ES; Okazaki H; Solingen S; Kobayashi Y; Karagueuzian HS; Mandel WJ
    Am Heart J; 1991 Nov; 122(5):1355-60. PubMed ID: 1951000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nitric oxide synthase modulation on resuscitation success in a swine ventricular fibrillation cardiac arrest model.
    Zhang Y; Boddicker KA; Rhee BJ; Davies LR; Kerber RE
    Resuscitation; 2005 Oct; 67(1):127-34. PubMed ID: 16039037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.
    Saksena S; Tullo NG; Krol RB; Mauro AM
    Arch Intern Med; 1989 Oct; 149(10):2333-9. PubMed ID: 2802898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acute and prolonged administration of propafenone on internal defibrillation in the pig.
    Natale A; Montenero AS; Bombardieri G; Barilaro C; Kim YH; Klein GJ; Jones DL
    Am Heart J; 1992 Jul; 124(1):104-9. PubMed ID: 1615791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oral propafenone on defibrillation and pacing thresholds in patients receiving implantable cardioverter-defibrillators. Propafenone Defibrillation Threshold Investigators.
    Stevens SK; Haffajee CI; Naccarelli GV; Schwartz KM; Luceri RM; Packer DL; Rubin AM; Kowey PR
    J Am Coll Cardiol; 1996 Aug; 28(2):418-22. PubMed ID: 8800119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of defibrillation efficacy using implantable cardioverter-defibrillator with single- or dual-coil defibrillation leads and active can.
    Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Raczak G; Swiatecka G
    Kardiol Pol; 2005 Sep; 63(3):234-41; discussion 242-3. PubMed ID: 16180177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-coil vs single-coil active pectoral implantable defibrillator lead systems: defibrillation energy requirements and probability of defibrillation success at multiples of the defibrillation energy requirements.
    Schulte B; Sperzel J; Carlsson J; Schwarz T; Ehrlich W; Pitschner HF; Neuzner J
    Europace; 2001 Jul; 3(3):177-80. PubMed ID: 11467457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of myocardial infarction on catheter defibrillation threshold.
    Babbs CF; Paris RL; Tacker WA; Bourland JD
    Med Instrum; 1983; 17(1):18-20. PubMed ID: 6843409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial ischaemic preconditioning in the pig has no effect on the ventricular fibrillation and defibrillation thresholds.
    Anastasiou-Nana MI; Tsagalou EP; Mavrikakis EM; Siafakas KX; Tsolakis EJ; Drakos SG; Dalianis A; Karelas J; Terrovitis JV; Nanas JN
    Resuscitation; 2005 Mar; 64(3):373-6. PubMed ID: 15733768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical open-chest ventricular defibrillation: triphasic waveforms are superior to biphasic waveforms.
    Zhang Y; Boddicker KA; Davies LR; Jones JL; Kerber RE
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):941-8. PubMed ID: 15271014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The implantable automatic cardioverter-defibrillator].
    Klein H; Tröster J; Trappe HJ; Becht I; Siclari F
    Herz; 1990 Apr; 15(2):111-25. PubMed ID: 2188891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular defibrillation with myocardial electrodes in the dog, calf, pony, and pig.
    Gold JH; Schuder JC; Stoeckle H
    Med Instrum; 1980; 14(1):19-22. PubMed ID: 7354731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of shock polarity reversal on defibrillation threshold in an implantable cardioverter-defibrillator.
    Zienciuk A; Lubiński A; Królak T; Lewicka-Nowak E; Kempa M; Pazdyga A; Raczak G
    Kardiol Pol; 2007 May; 65(5):495-500; discussion 501-2. PubMed ID: 17577846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal timing for electrical defibrillation after prolonged untreated ventricular fibrillation.
    Kolarova J; Ayoub IM; Yi Z; Gazmuri RJ
    Crit Care Med; 2003 Jul; 31(7):2022-8. PubMed ID: 12847399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sildenafil citrate on defibrillation efficacy.
    Shinlapawittayatorn K; Sungnoon R; Chattipakorn S; Chattipakorn N
    J Cardiovasc Electrophysiol; 2006 Mar; 17(3):292-5. PubMed ID: 16643403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pericardial influence on internal defibrillation energy requirements.
    Lemmer JH; Faber LA; Mariano DJ; Drews TA; Kienzle MG; Behrendt DM
    J Thorac Cardiovasc Surg; 1991 May; 101(5):839-42. PubMed ID: 2023440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of the intraoperative defibrillation threshold to successful postoperative defibrillation with an automatic implantable cardioverter defibrillator.
    Marchlinski FE; Flores B; Miller JM; Gottlieb CD; Hargrove WC
    Am J Cardiol; 1988 Sep; 62(7):393-8. PubMed ID: 3414516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of transient myocardial ischemia on the ventricular defibrillation threshold.
    Anastasiou-Nana MI; Tsagalou EP; Charitos C; Siafakas KX; Drakos S; Terrovitis JV; Ntalianis A; Doufas A; Mavrikakis J; Nanas JN
    Pacing Clin Electrophysiol; 2005 Feb; 28(2):97-101. PubMed ID: 15679638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.